Cutting Clinical Trial Site Training Burden by 25%
The SCRS Cut 25 initiative set a clear target: reduce clinical trial site training burden by 25%....
Featured contributor to the SCRS initiative reducing redundant site training by 25%+
The Patient Perspective in Oncology Research Participation
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Screen failures in clinical research are a necessary, unpredictable, and disruptive part of the...
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
Don’t believe the hype. Most patient dropouts CANNOT be avoided. In my 23 years of clinical...
ProofPilot’s acquisition of Lokavant will have a strong, direct impact on clinical trial...
The SCRS Cut 25 initiative set a clear target: reduce clinical trial site training burden by 25%....
It’s one of the most well-documented problems in clinical research, yet year after year, it...
Imagine you’re the head of clin ops at a fledging biotech. Today you’re working with one molecule...
Over the past year, ProofPilot truly leveled up—we generated amazing customer experiences, joined...
ProofPilot’s acquisition of Lokavant will have a strong, direct impact on clinical trial...
In clinical research, adopting new technology to solve important challenges is often a colossal...
The success of a clinical trial is often measured with metrics and milestones. But patient advocate...